HopeStage
Back to all studies
CompletedNCT02670538

Cariprazine for Bipolar I Depression: Study 1

About this title

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

Read the official source — NCT02670538

Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

Medication studyAges 18–65Multiple countries
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Birmingham and 88 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 31, 2016
Recruitment status
Completed
Enrollment listed in the registry
493
Sponsor
Forest Laboratories
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Bulgaria, Croatia, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT02670538
Official title
Show the full official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham, United States · Dothan, United States · Phoenix, United States

70 more locations
  • Little Rock, United States
  • Anaheim, United States
  • Cerritos, United States
  • Garden Grove, United States
  • Glendale, United States
  • Oceanside, United States
  • Torrance, United States
  • Washington D.C., United States
  • Coral Springs, United States
  • Hallandale, United States
  • Lauderhill, United States
  • Miami, United States
  • Oakland Park, United States
  • Atlanta, United States
  • Hoffman Estates, United States
  • Libertyville, United States
  • Naperville, United States
  • Shreveport, United States
  • Weymouth, United States
  • Creve Coeur, United States
  • St Louis, United States
  • Cherry Hill, United States
  • Marlton, United States
  • Brooklyn, United States
  • Buffalo, United States
  • New York, United States
  • Rochester, United States
  • Hickory, United States
  • Cincinnati, United States
  • Mason, United States
  • Oklahoma City, United States
  • Tulsa, United States
  • Media, United States
  • Charleston, United States
  • Houston, United States
  • Wichita Falls, United States
  • Bothell, United States
  • Burgas, Bulgaria
  • Kazanlak, Bulgaria
  • Pleven, Bulgaria
  • Plovdiv, Bulgaria
  • Varna, Bulgaria
  • Popovača, Croatia
  • Rijeka, Croatia
  • Zagreb, Croatia
  • San Juan, Puerto Rico
  • Bucharest, Romania
  • Galati, Romania
  • Iași, Romania
  • Belgrade, Serbia
  • Kragujevac, Serbia
  • Niš, Serbia
  • Novi Kneževac, Serbia
  • Bardejov, Slovakia
  • Bratislava, Slovakia
  • Liptovský Mikuláš, Slovakia
  • Rimavská Sobota, Slovakia
  • Rožňava, Slovakia
  • Vranov nad Topľou, Slovakia
  • Hlevakha, Ukraine
  • Ivano-Frankivsk, Ukraine
  • Kharkiv, Ukraine
  • Kherson, Ukraine
  • Komintern, Ukraine
  • Lviv, Ukraine
  • Odesa, Ukraine
  • Smila, Ukraine
  • Ternopil, Ukraine
  • Uzhhorod, Ukraine
  • Vinnytsia, Ukraine

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

Who is behind this study?

The study sponsor is Forest Laboratories, a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including Cariprazine and Placebo.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies